Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial
ConclusionsThe present study demonstrated that adjunctive consumption of okra, in type 2 diabetic patients with 1000 mg three times a day for three months, improves lipid profile, glycemic control, and chronic inflammation without any tangible adverse effects.Clinical Trial Registry: IRCT.Ir (IRCT20120112008712N2).https://www.irct.ir/trial/42042.Graphical abstract
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
More News: Cholesterol | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Endocrinology | Fortamet | Fruit | Herbs | Insulin | Liver | Metformin | Nutrition | Study | Urology & Nephrology